Evidence map›Paper›PMID 32028796›Full record

ArticleCartilage2021

The Influence of a Single Intra-Articular Lidocaine Injection on the Viability of Articular Cartilage in the Knee.

Klemen Ravnihar, Tomaž Marš, Sergej Pirkmajer, Armin Alibegović, Gordana Koželj, Andraž Stožer, Matej Drobnič

Open access · bronzeAbstract read
In one paragraph

Article in Cartilage, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Klemen RavniharValdoltra Orthopaedic Hospital, Ankaran, Slovenia.ORCID 0000-0002-2632-4236
Tomaž MaršInstitute for Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Sergej PirkmajerInstitute for Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Armin AlibegovićInstitute of Forensic Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Gordana KoželjDepartment of Toxicology, Institute of Forensic Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Andraž StožerInstitute of Physiology, Medical Faculty, University of Maribor, Maribor, Slovenia.
Matej DrobničDepartment of Orthopedic Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia.
University of Ljubljana · SILjubljana University Medical Centre · SIOrthopaedic Hospital Valdoltra · SIUniversity of Maribor · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the

designThis study includes 3 interconnected experiments: (A) Synovial LA concentration measurement after a 2% lidocaine injection before knee arthroscopy in 10 patients by liquid chromatography-tandem mass spectrometry (LC-MS/MS). (B) Human osteochondral explants (

results(A) The synovial LA concentration was significantly lower than the primary concentration injected: average 0.23 mg/mL (0.02%), highest measured 0.37 mg/mL (0.04%). (B)

conclusionsA single intra-articular knee injection of 2% lidocaine did not influence the chondrocyte viability neither in healthy nor in OA cartilage. A fast postinjection reduction of synovial LA concentration (more than 40 times) is the most likely protective mechanism.

Indexed as

Cartilage, ArticularChromatography, LiquidHumansInjections, Intra-ArticularLidocaineTandem Mass SpectrometryLidocainearticular cartilagecellschondrocytesconfocal laser microscopylidocainelocal anaesthetictissue

Identifiers

PMID32028796
PMCPMC8808909
OpenAlexW3005166692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.